Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: A systematic review

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 28, Issue 2, 2011, Pages 87-94

  Treglia, Giorgio ^a   Taralli, S ^a   Giordano, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

18F FDG; Positron emission tomography; Sarcoidosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CONTROLLED STUDY; DISEASE ACTIVITY; HUMAN; MAJOR CLINICAL STUDY; MEDLINE; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; SARCOIDOSIS; SEVERITY OF ILLNESS INDEX; WHOLE BODY IMAGING;

EID: 81455131960     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Morgenthau AS, Iannuzzi MC. Recent advances in sarcoidosis. Chest 2011; 139: 174-82.
2. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357: 2153-65.
3. ATS/ERS/WASOG Committee. Statement on Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-73.
4. Nunes H, Soler P, Valeyre D. Pulmonary sarcoidosis. Allergy 2005; 60: 565-82. (Pubitemid 40562463)
5. Koyama T, Ueda H, Togashi K, Umeoka S, Kataoka M, Nagai S. Radiologic manifestations of sarcoidosis in various organs. Radiographics 2004; 24: 87-104. (Pubitemid 38134596)
6. Gotthardt M, Bleeker-Rovers CP, Boerman OC, Oyen WJ. Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J Nucl Med 2010; 51: 1937-49.
7. Basu S, Zhuang H, Torigian DA, Rosenbaum J, Chen W, Alavi A. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med 2009; 39: 124-45.
8. Bakheet S, Powe J. Benign causes of 18-FDG uptake on whole-body imaging. Semin Nucl Med 2000; 28: 352-8. (Pubitemid 28478048)
9. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-deoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33: 1972-80.
10. Bleeker-Rovers CP, Vos FJ, Corstens FH, Oyen WJ. Imaging of infectious diseases using [18F] fluorodeoxyglucose PET. QJ Nucl Med Mol Imaging 2008; 52: 17-29. (Pubitemid 351351041)
11. Treglia G, Cason E, Fagioli G. Recent applications of nuclear medicine in diagnostics: II part. Italian Journal of Medicine 2010; 4: 159-66.
12. Lewis PJ, Salama A. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. J Nucl Med 1994; 35: 1647-9.
13. Yamada Y, Uchida Y, Tatsumi K, et al. Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis. J Nucl Med 1998; 39: 1160-6. (Pubitemid 28326144)
14. Nishiyama Y, Yamamoto Y, Fukunaga K, et al. Comparative evaluation of 18F-FDG-PET and 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 2006; 47: 1571-6. (Pubitemid 47545019)
15. Kaira K, Oriuchi N, Otani Y, et al. Diagnostic usefulness of fluorine-18-alpha-methylfyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients. Chest 2007; 131: 1019-27. (Pubitemid 46608702)
16. Teirstein AS, Machac J, Almeida O, Lu P, Padilla ML, Iannuzzi MC. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 2007; 132: 1949-53.
17. Prager E, Wehrschuetz M, Bisail B, et al. Comparison of 18F-FDG and 67Ga-citrate in sarcoidosis imaging. Nuklearmedizin 2008; 47: 18-23. (Pubitemid 351272806)
18. Braun JJ, Kessler R, Constantinesco A, Imperiale A. 18F-FDG-PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging 2008; 35: 1537-43.
19. Keijsers RG, Verzijlbergen JF, van Diepen DM, van den Bosch JM, Gratters JC. 18F-FDG-PET in sarcoidosis: an observational study in 12 patients treated with infliximab. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25: 143-9.
20. Keijsers RG, Verzijlbergen FJ, Oyen WJ, et al. 18F-FDG-PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis. Eur J Nucl Med Mol Imaging 2009; 36: 1131-7.
21. Keijsers RG, Gratters JC, van Velzen-Blad H, van den Bosch JM, Oyen WJ, Verzijlbergen FJ. (18)F-FDG-PET patterns and BAL cell profiles in pulmonary sarcoidosis. Eur J Nucl Med Mol Imaging 2010; 37: 1181-8.